Clinicopathological details
| Number | IL-21 | pERK1/2 | ||||
|---|---|---|---|---|---|---|
| Parameters | Mean±SD | p Value | Weak expression | Over expression | p Value | |
| Gender | ||||||
| Male | 14 | 1 726 384 ±1 385 693 | 0.519 | 3* | 11 | 0.999 |
| Female | 4 | 1 236 822±896 356 | 1 | 3 | ||
| Age (years) | ||||||
| <35 | 9 | 2 027 178±1 558 506 | 0.184 | 1 | 8 | 0.576 |
| ≥35 | 9 | 1 208 007±841 626 | 3 | 6 | ||
| Eosinophils | ||||||
| <20% | 7 | 1 448 195±1 184 142 | 0.669 | 2 | 5 | 0.999 |
| ≥20% | 11 | 1 725 391±1 391 979 | 2 | 9 | ||
| Location | ||||||
| Head and neck | 14 | 1 351 625±1 127 872 | 0.102 | 3 | 11 | 0.999 |
| General | 4 | 2 548 478±1 541 010 | 1 | 3 | ||
| Multiplicity | ||||||
| Single | 6 | 1 200 026±1 463 319 | 0.345 | 1 | 5 | 0.999 |
| Multiple | 12 | 1 826 376±1 200 080 | 3 | 9 | ||
| Laterality | ||||||
| Unilateral | 10 | 1 553 860±1 553 879 | 0.822 | 1 | 9 | 0.275 |
| Bilateral | 8 | 1 697 258±948 355 | 3 | 5 | ||
| Size (cm)† | ||||||
| <3.5 | 3 | 1 314 675±1 073 772 | 0.637 | 1 | 2 | 0.999 |
| ≥3.5 | 14 | 1 727 476±1 385 951 | 3 | 11 | ||
| Duration (years) | ||||||
| <5 | 9 | 1 616 774±1 539 777 | 0.998 | 3 | 6 | 0.576 |
| ≥5 | 9 | 1 618 411±1 069 496 | 1 | 8 | ||
| Primary outbreak | ||||||
| Recurrent | 7 | 1 681 368±1 467 344 | 0.873 | 0 | 7 | 0.119 |
| Primary | 11 | 1 577 008±1 230 964 | 4 | 7 | ||
| Outcome‡ | ||||||
| Recurrent | 7 | 782 388±674 181 | 0.049 | 4 | 3 | 0.019 |
| Recurrence-free | 9 | 1 757 997±1 036 945 | 0 | 9 | ||
*Data are presented as number of patients.
†Data lost.
‡Lost in follow-up.
IL, interleukin.